tiprankstipranks
Annexon Biosciences (ANNX)
NASDAQ:ANNX
US Market
ANNX
Annexon Biosciences
RESEARCH TOOLSreports

Annexon Biosciences (ANNX) Financial Statements

Compare
1,391 Followers

Annexon Biosciences Financial Overview

Annexon Biosciences's market cap is currently $723.64M. The company's EPS TTM is $; its P/E ratio is -2.07; Annexon Biosciences is scheduled to report earnings on March 9, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ -3.45M$ 0.00$ 0.00$ 0.00$ 0.00
Operating Income$ -154.07M$ -143.72M$ -145.60M$ -130.71M$ -63.47M
EBITDA$ -134.75M$ -141.57M$ -143.45M$ -128.57M$ -62.80M
Net Income$ -138.20M$ -134.24M$ -141.95M$ -130.32M$ -63.41M
Balance Sheet
Cash & Short-Term Investments$ 312.02M$ 259.72M$ 242.66M$ 242.72M$ 351.21M
Total Assets$ 350.07M$ 297.67M$ 285.10M$ 287.04M$ 355.95M
Total Debt$ 28.97M$ 31.36M$ 32.86M$ 34.59M$ 0.00
Net Debt$ -20.53M$ -193.75M$ -107.16M$ -40.25M$ -268.56M
Total Liabilities$ 56.97M$ 47.12M$ 53.90M$ 55.13M$ 11.67M
Stockholders' Equity$ 293.11M$ 250.56M$ 231.19M$ 231.91M$ 344.28M
Cash Flow
Free Cash Flow$ -118.02M$ -121.33M$ -122.83M$ -107.76M$ -53.55M
Operating Cash Flow$ -118.01M$ -121.14M$ -116.31M$ -106.11M$ -53.09M
Investing Cash Flow$ -218.80M$ 70.70M$ 58.44M$ -88.24M$ -83.16M
Financing Cash Flow$ 161.21M$ 135.52M$ 122.91M$ 1.79M$ 360.88M
Currency in USD

Annexon Biosciences Earnings and Revenue History

Income Statement >

Annexon Biosciences Debt to Assets

Balance Sheet >

Annexon Biosciences Cash Flow

Cash Flow >

Annexon Biosciences Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
Earnings >